Celtique Energie Overview
- Founded
- 2004

- Status
- Out of Business
- Employees
- 4

- Latest Deal Type
- Liquidation
- Financing Rounds
- 3
- Investments
- 2
Celtique Energie General Information
Description
Operator of oil and gas exploration company. The company develops and explores oil and natural gas in onshore basins utilizing modern geophysical technology to generate attractive opportunities for oil and gas development.
Contact Information
- C/o Rawlinson & Hunter, Eighth Floor
- 6 New Street Square, New Fetter Lane
- London EC4A 3AQ
- England, United Kingdom
Celtique Energie Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Celtique Energie‘s full profile, request access.
Request a free trialCeltique Energie Comparisons
Industry
0000 000
00 00000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCeltique Energie Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Dana Petroleum | Formerly VC-backed | Aberdeen, United Kingdom | 000 | 00000 | 00000000000 | |
00 000000 | Corporation | Subiaco, Australia | 0 | 00000 | 000000000 | 00000 |
000000 000000 | Corporate Backed or Acquired | Aberdeen, United Kingdom | 00 | 00000 | 000000000 00 | 00000 |
000 000 0000000 | Corporate Backed or Acquired | Sydney, Australia | 000 | 00000 | 000000&0 | 00000 |
00000 | Corporation | West Perth, Australia | 00 | 00.00 | 000000000 | 00.00 |
Celtique Energie Patents
Celtique Energie Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2018285823-A1 | Tinostamustine for use in treating ovarian cancer | Pending | 13-Jun-2017 | 00000000000 | |
CA-3067052-A1 | Tinostamustine for use in treating ovarian cancer | Pending | 13-Jun-2017 | 00000000000 | |
GB-201709405-D0 | Compounds for treating ovarian cancer | Ceased | 13-Jun-2017 | 00000000000 | |
US-20200261423-A1 | Tinostamustine for use in treating ovarian cancer | Pending | 13-Jun-2017 | 00000000000 | |
JP-2020523356-A | Tinostamustine for use in treating ovarian cancer | Pending | 13-Jun-2017 | A61K31/4184 |
Celtique Energie Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCeltique Energie Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 000 0000 | 01-Jan-2011 | 000000000 | Buildings and Property | ||
PEDL 182 Broughton North | 01-Jan-2011 | Corporate Asset Purchase | Buildings and Property |